Live Breaking News & Updates on Theralink Technologies Inc

Stay updated with breaking news from Theralink technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023

Theralink Technologies, Inc. reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was USD 0.606796 million compared to USD 0.567905. ....

Theralink Technologies Inc , Theralink Technologies ,

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to. ....

United States , San Francisco , Trevor Mccartney , Emanuelf Petricoin , Globenewswire Inc , University Professor , University Of California , George Mason University , Theralink Technologies Inc , Securities Exchange , Mason Science School Of Systems Biology , Exchange Commission , Mason University , Cell Reports Medicine , Response Predictive Signature , Triple Negative Breast Cancer , Applied Proteomics , Molecular Medicine , Breast Cancer , Distinguished University Professor , Science School , Reverse Phase Protein Array , Securities Act , Securities Exchange Act , Merger Agreement , Quarterly Reports ,

Theralink® and IMAC Holdings announce receipt and response

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision. ....

United States , Trevor Mccartney , Exchange Commission , Theralink Technologies Inc , Holdings Inc , Securities Exchange , Chief Executive Officer , Faith Zaslavsky , Theralink Technologies , Reverse Phase Protein Array , Securities Act , Securities Exchange Act , Merger Agreement , Quarterly Reports , Current Reports , Annual Reports , Other Otc Ther , Theralink Technologies , Tc Ther , Exchange Commission , Da Approved Drug ,

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Trevor Mccartney , Securities Exchange , Exchange Commission , Holdings Inc , Gastrointestinal Cancer Program At Inova , Inova Schar Cancer Institute , Theralink Technologies Inc , Molecular Tumor Board , Inova Schar Molecular Tumor , Inova Schar Cancer , Faith Zaslavsky , Chief Executive Officer , Timothy Cannon , Sheridan Director , Inova Molecular Tumor Board , Gastrointestinal Cancer Program , Theralink Technologies , Reverse Phase Protein Array , Securities Act , Securities Exchange Act , Merger Agreement , Quarterly Reports , Current Reports , Annual Reports , Multi Omic Data ,

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board -November 03, 2023 at 09:16 am EDT

Golden, Colorado, Nov. 03, 2023 Theralink Technologies, Inc. , a precision oncology company with its exclusive commercial RPPA technology that can help predict which FDA-approved drug is. ....

United States , Trevor Mccartney , Exchange Commission , Inova Schar Cancer Institute , Gastrointestinal Cancer Program , Securities Exchange , Holdings Inc , Theralink Technologies Inc , Globenewswire Inc , Schar Cancer Institute , Molecular Tumor Board , Inova Schar Molecular Tumor , Schar Cancer , Chief Executive Officer , Inova Molecular Tumor Board , Reverse Phase Protein Array , Securities Act , Securities Exchange Act , Merger Agreement , Quarterly Reports , Current Reports , Annual Reports , Multi Omic Data , Molecular Tumor Board Reveals , Inhibitor Resistance , Patient With Inflammatory Myofibroblastic ,